scholarly article | Q13442814 |
P2093 | author name string | Gianluigi Zaza | |
Antonio Lupo | |||
Simona Granata | |||
Valentina Masola | |||
Giovanni Gambaro | |||
Luigi Dall'Olmo | |||
Maurizio Onisto | |||
Gisella Vischini | |||
Gloria Bellin | |||
P2860 | cites work | Hospital Mortality in the United States following Acute Kidney Injury | Q26744765 |
Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases | Q28475274 | ||
Protective effect of EDTA preadministration on renal ischemia | Q33236469 | ||
Origin and function of myofibroblasts in kidney fibrosis | Q33792700 | ||
MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells | Q33938788 | ||
The relationship between nephron number, kidney size and body weight in two inbred mouse strains | Q34157117 | ||
Endothelin-1 gene regulation | Q34421747 | ||
Nitric oxide in acute renal failure: NOS versus NOS. | Q34534561 | ||
Acute kidney injury increases risk of ESRD among elderly | Q34657680 | ||
Endothelial surface glycocalyx can regulate flow-induced nitric oxide production in microvessels in vivo | Q34894458 | ||
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells | Q35668839 | ||
Recent data concerning heparanase: focus on fibrosis, inflammation and cancer | Q35836200 | ||
Heparanase Inhibition Reduces Glucose Levels, Blood Pressure, and Oxidative Stress in Apolipoprotein E Knockout Mice | Q46068605 | ||
Postconditioning protects renal fibrosis by attenuating oxidative stress-induced mitochondrial injury | Q46397391 | ||
The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies. | Q47207922 | ||
Renal fibrosis: Recent translational aspects. | Q47239851 | ||
Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets. | Q47305480 | ||
Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis | Q47872090 | ||
Chronic kidney disease, kidney transplantation and oxidative stress: a new look to successful kidney transplantation | Q49190327 | ||
Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond | Q49340131 | ||
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury. | Q50262560 | ||
Chronic NOS inhibition actuates endothelial-mesenchymal transformation. | Q50715902 | ||
Phase I study of the heparanase inhibitor Roneparstat: an innovative approach for multiple myeloma therapy. | Q52560290 | ||
Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies. | Q52674866 | ||
Association between endothelin-1/endothelin receptor A and inflammation in mouse kidneys following acute ischemia/reperfusion. | Q53649394 | ||
Fibroblasts emerge via epithelial-mesenchymal transition in chronic kidney fibrosis | Q58214788 | ||
The tubulointerstitium in progressive renal disease | Q77291600 | ||
Protecting the microvasculature: a Tie-ght connection to ameliorating chronic kidney disease? | Q80087712 | ||
Endothelin receptors in the kidney of patients with proteinuric and non-proteinuric nephropathies | Q80158752 | ||
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury | Q36088435 | ||
Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria | Q36098881 | ||
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis | Q36104434 | ||
Chronic renal allograft dysfunction | Q36240051 | ||
Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure | Q36314459 | ||
The endothelin system and its antagonism in chronic kidney disease | Q36422620 | ||
Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis | Q36589609 | ||
Oxidative stress and autophagy: crucial modulators of kidney injury | Q36717785 | ||
Nitric oxide and vascular remodeling: spotlight on the kidney | Q36891974 | ||
Reversal of proteinuric renal disease and the emerging role of endothelin. | Q37224296 | ||
Renal tubulointerstitial fibrosis: common but never simple. | Q37368710 | ||
Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1. | Q37679989 | ||
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects | Q38220834 | ||
Acute kidney injury and chronic kidney disease as interconnected syndromes | Q38225657 | ||
Molecular Dissection of Renal Ischemia-Reperfusion: Oxidative Stress and Cellular Events. | Q38693936 | ||
Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases | Q38801721 | ||
The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis | Q38806534 | ||
Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma | Q38815363 | ||
EMT: 2016. | Q38883448 | ||
Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis. | Q38884230 | ||
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity | Q38983916 | ||
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. | Q39033979 | ||
The advancements of heparanase in fibrosis | Q39080564 | ||
Ischemia/Reperfusion | Q39109413 | ||
Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease | Q39120713 | ||
Epithelial to Mesenchymal Transition (EMT) and Endothelial to Mesenchymal Transition (EndMT): Role and Implications in Kidney Fibrosis | Q39242491 | ||
Dialysis-related transcriptomic profiling: the pivotal role of heparanase | Q39321185 | ||
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease | Q39429579 | ||
Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx | Q39879255 | ||
Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease | Q40666383 | ||
The role of oxygen free radicals in mediating the reperfusion injury of cold-preserved ischemic kidneys | Q41487761 | ||
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. | Q41855773 | ||
The hemopexin domain of matrix metalloproteinase-9 activates cell signaling and promotes migration of schwann cells by binding to low-density lipoprotein receptor-related protein | Q41912504 | ||
Renal ischemia-reperfusion leads to long term infiltration of activated and effector-memory T lymphocytes | Q41922589 | ||
Hypoxia Induces Mesenchymal Gene Expression in Renal Tubular Epithelial Cells: An in vitro Model of Kidney Transplant Fibrosis | Q43092586 | ||
Heparanase and macrophage interplay in the onset of liver fibrosis | Q43812376 | ||
L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation | Q43936722 | ||
L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats | Q44465907 | ||
Identifying specific causes of kidney allograft loss. | Q45810388 | ||
P433 | issue | 90 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | reperfusion injury | Q1413991 |
P304 | page(s) | 36185-36201 | |
P577 | publication date | 2018-11-16 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury | |
P478 | volume | 9 |
Search more.